Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Takeda’s Entyvio: benefit of real-world data in GI diseases
  2. FDA approves Janssen’s Stelara for adults with UC

Company A-Z

Latest Content

Takeda’s Entyvio: benefit of real-world data in GI diseases

Takeda has published promising real-world data for its UC and CD drug Entyvio, which suggest the drug is better tolerated by patients than four anti-TNFα therapies. Takeda’s Global Gastroenterology Outcomes Research head Michelle Luo explains the results of the study and the benefits of real world studies for patients with these gastrointestinal diseases.

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top